Vericel (VCEL) Gross Margin Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Vericel | 1.69 Bn | 1.55 Bn | 49.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 365.00 |
| Dec 31, 2025 | 431.00 |
| Sep 30, 2025 | 380.00 |
| Jun 30, 2025 | 1,698.00 |
| Mar 31, 2025 | 615.00 |
| Dec 31, 2024 | 448.00 |
| Sep 30, 2024 | 250.00 |
| Jun 30, 2024 | 400.00 |
| Mar 31, 2024 | 856.00 |
| Dec 31, 2023 | 217.00 |
| Sep 30, 2023 | 335.00 |
| Jun 30, 2023 | 584.00 |
| Mar 31, 2023 | 718.00 |
| Dec 31, 2022 | 851.00 |
| Sep 30, 2022 | 1,585.00 |
| Jun 30, 2022 | 693.00 |
| Mar 31, 2022 | 4,136.00 |
| Dec 31, 2021 | 744.00 |
| Sep 30, 2021 | 2,677.00 |
| Jun 30, 2021 | 2,502.00 |
| Mar 31, 2021 | 1,485.00 |
| Dec 31, 2020 | 2,127.00 |
| Sep 30, 2020 | 2,954.00 |
| Jun 30, 2020 | 751.00 |
| Mar 31, 2020 | 1,413.00 |
| Dec 31, 2019 | 1,904.00 |
| Sep 30, 2019 | 2,671.00 |
| Jun 30, 2019 | 7,852.00 |
| Dec 31, 2018 | -1,504.00 |
| Jun 30, 2018 | -731.00 |
| Mar 31, 2018 | -1,753.00 |
| Dec 31, 2017 | -1,487.00 |
| Sep 30, 2016 | -4,051.00 |
| Mar 31, 2016 | -2,428.00 |